• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc REGN 3 Star

Last Price$350.46Day Change (%)1.02%
Open Price$349.10Day Change ($)3.54
Day Range346.20–350.7452-Week Range237.88–354.79

As of Fri 08/29/2014 05:50 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Robbins Arroyo LLP Is Investigating the Officers and Directors of Regeneron Pharmaceuticals , Inc. on Behalf of Shareholders

    Robbins Arroyo LLP Is Investigating the Officers and Directors of Regeneron Pharmaceuticals , Inc. on Behalf of Shareholders

  2. Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

    Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

  3. EYLEA® (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)

    EYLEA® (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)

  4. Bayer's EYLEA Granted EU Approval to Treat Impaired Vision

    Bayer's EYLEA Granted EU Approval to Treat Impaired Vision

  5. Regeneron Reports Second Quarter 2014 Financial and Operating Results

    Regeneron Reports Second Quarter 2014 Financial and Operating Results

  6. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  7. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  8. Our 5 Nominees for Domestic-Stock Fund Manager of the Year

    Standing out in a good year for stocks.

  9. Aberdeen to Buy Artio Global Investors

    As part of Aberdeen's acquisition of Artio, some international fund managers to depart. Also, a management change on a T. Rowe Price health-care fund, Columbia hires Putnam's former asset-allocation head, and ClearBridge and Legg Mason Capital Management funds to merge.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.